Dernière mise à jour :
19/11/2024
Equipes de recherche - Genentech, Inc   pdf  
Etats Unis d’Amérique
Laboratoire pharmaceutique
Genentech, Inc
San Francisco
Bibliographie   Bibliographie   (5)  
1
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. (zheng.kai@gene.com)
Int J Pharm Compound - 2021 - ;25,3:246-257
2
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. (sreedhaa@gene.com))
J Pharm Sci - 2012 - ; DOI 10.1002 / jps.23403
3
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. (lentz.yvonne@gene.com)
AAPS Pharm Sci - 2011 - ; 15, 2 : 264-272.
4
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. ()
Hemodial Int - 2011 - ; 15, 2 : 364-272.
5
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1904-1909.

Liste des molécules   Molécules étudiées   (13)  
Thrombolytique injectable Alteplase
Anticancéreux injectable Atezolizumab
Cardiotonique injectable Dobutamine hydrochloride
Cardiotonique injectable Dopamine hydrochloride
Anticoagulant injectable Heparin sodium
Anesthésique local injectable Lidocaine hydrochloride
Antiarythmique injectable Metoprolol tartrate
Antalgique injectable Morphine sulfate
Vasodilatateur injectable Nitroglycerin
Anticancéreux injectable Pertuzumab
Béta-bloquant injectable Propranolol hydrochloride
Thrombolytique injectable Tenecteplase
Anticancéreux injectable Trastuzumab

  Mentions Légales